Evidence map›Paper›PMID 36558389›Full record

ArticleNutrients2022

Effects of a Lifestyle Intervention in Young Women with GDM and Subsequent Diabetes.

Gang Hu, Huikun Liu, Junhong Leng, Leishen Wang, Weiqin Li, Shuang Zhang, Wei Li, Gongshu Liu, Huiguang Tian, Shengping Yang and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 5 countries.

Gang HuPennington Biomedical Research Center, 6400 Perkins Road, Baton Rouge, LA 70808, USA.ORCID 0000-0002-6172-8017
Huikun LiuTianjin Women's and Children's Health Center, Tianjin 300071, China.
Junhong LengTianjin Women's and Children's Health Center, Tianjin 300071, China.
Leishen WangTianjin Women's and Children's Health Center, Tianjin 300071, China.
Weiqin LiTianjin Women's and Children's Health Center, Tianjin 300071, China.
Shuang ZhangTianjin Women's and Children's Health Center, Tianjin 300071, China.
Wei LiTianjin Women's and Children's Health Center, Tianjin 300071, China.
Gongshu LiuTianjin Women's and Children's Health Center, Tianjin 300071, China.
Huiguang TianTianjin Women's and Children's Health Center, Tianjin 300071, China.
Shengping YangPennington Biomedical Research Center, 6400 Perkins Road, Baton Rouge, LA 70808, USA.
Zhijie YuPopulation Cancer Research Program, Dalhousie University, Halifax, NS B3H 4R2, Canada.
Xilin YangDepartment of Epidemiology and Biostatistics, School of Public Health, Tianjin Medical University, Tianjin 300070, China.ORCID 0000-0002-9462-7992
Jaakko TuomilehtoDepartment of Public Health, University of Helsinki, 00014 Helsinki, Finland.
Tianjin Children's Hospital · CNPennington Biomedical Research Center · USDalhousie University · CATianjin Medical University · CNUniversity of Helsinki · FI

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2012 to 2026
$69.1M
True Metal fac coreP30ES009089 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MATTHEW S PERZANOWSKI · 1998 to 2026
$44.7M
Research BaseP30DK072476 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2005 to 2026
$26.5M
Methylomics of prenatal GDM: Natural history & lifestyle intervention in childrenR01DK100790 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI BACCARELLI, ANDREA, HOU, LIFANG · 2014 to 2017
$2.6M
Biomarker of Pancreatic B-cell Loss Predicting Progression to Type 2 Diabetes After Gestational DiabetesR01DK132011 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Gang Hu, Yeyi Zhu · 2023 to 2026
$2.6M
NIDDK NIH HHS P30 DK072476NIDDK NIH HHS R01 DK100790NIDDK NIH HHS R01DK100790NIDDK NIH HHS R01 DK132011NIEHS NIH HHS P30 ES009089NIGMS NIH HHS U54 GM104940NIGMS NIH HHS U54GM104940
6 · The paper itself

Abstract

The purpose of this study was to examine whether a 9-month intensive lifestyle intervention could lead to weight loss and improve cardiovascular risk factors among young women with both gestational diabetes mellitus (GDM) and newly diagnosed diabetes. A total of 83 young women, who had GDM and were subsequently diagnosed as type 2 diabetes at an average of 2.6 years after delivery, participated in a 9-month intensive lifestyle intervention and a follow-up survey at 6-9 years postintervention. After the 9-month intervention, these women had a weight loss of 2.90 kg (-4.02% of initial weight), decreased waist circumference (-3.12 cm), body fat (-1.75%), diastolic blood pressure (-3.49 mmHg), fasting glucose (-0.98 mmol/L) and HbA1c (-0.72%). During the 6-9 years postintervention period, they still had lower weight (-3.71 kg; -4.62% of initial weight), decreased waist circumference (-4.56 cm) and body fat (-2.10%), but showed a slight increase in HbA1c (0.22%). The prevalence of using glucose-lowering agents increased from 2.4% at baseline to 34.6% after the 9-month lifestyle intervention, and to 48.4% at 6-9 years postintervention. A 9-month intensive lifestyle intervention can produce beneficial effects on body weight, HbA1c and other cardiovascular risk factors among young women with previous GDM who subsequently developed new diabetes.

Indexed as

Diabetes, GestationalDiabetes Mellitus, Type 2Blood GlucoseBody Mass IndexFemaleGlucoseGlycated HemoglobinHumansLife StylePregnancyWeight LossBlood GlucoseGlucoseGlycated Hemoglobingestational diabetes mellituslifestyle interventionpostpartumtype 2 diabetes

Identifiers

PMID36558389
PMCPMC9785424
OpenAlexW4311970897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.